Ingredion (INGR) shares tumbled 5.20% in pre-market trading on Tuesday following the release of its third-quarter 2025 earnings report, which fell short of analyst expectations and included a downward revision to its full-year sales forecast.

The ingredient solutions provider reported Q3 adjusted earnings per share (EPS) of $2.75, missing the IBES estimate of $2.92. Sales for the quarter came in at $1,816 million, significantly below the expected $1,903 million. This underperformance in both earnings and revenue likely contributed to the negative market reaction.

Adding to investor concerns, Ingredion updated its outlook for the full year 2025. The company now expects net sales to be "flat to down low single-digits," a downward revision from previous guidance. Despite the sales pressure, Ingredion maintained its full-year adjusted EPS forecast in the range of $11.1 to $11.3. The company also provided its capital expenditure outlook for the fiscal year, projecting CAPEX between $400 million and $425 million.